1542705-92-9 (CB-5083,CB-5083)

CB5083 抑制剂;

CB-5083;CB5083;591IV6UL6J;AK173785;1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide;1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide;BCP23807;CB 5083;S8101;J3.551.815K;1-(7,8-Dihydro-4-((phenylmethyl)amino)-5H-pyrano(;1542705-92-9;CCG-268805;BDBM50500325;p97 Inhibitor CB-5083;HY-12861;UNII-591IV6UL6J;BRD-K49048664-001-02-0;CB-5083; CB 5083;EX-A773;MFCD28963914;BRD-K49048664-001-01-2;(1-(4-(benzylamino)-5H,7H,8H-pyrano(4,3-d)pyrimidin-2-yl))-2-methyl-1H-indole-4-carboxamide;DTXSID801022542;BC177445;1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methylindole-4-carboxamide;CHEMBL3747513;CB 5083 [WHO-DD];CB-5083?;AC-29018;NSC786100;CS-5405;NSC-786100;JDP;AS-55872;AKOS025396184;NCGC00481317-01;SCHEMBL15421452;1-[4-(BENZYLAMINO)-5H,7H,8H-PYRANO[4,3-D]PYRIMIDIN-2-YL]-2-METHYLINDOLE-4-CARBOXAMIDE;1-(7,8-Dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide;1H-Indole-4-carboxamide, 1-(7,8-dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-;NCGC00481317-03;DA-71987;HMS3873E13;

MFCD28963914

RDALZZCKQFLGJP-UHFFFAOYSA-N

1S/C24H23N5O2/c1-15-12-18-17(22(25)30)8-5-9-21(18)29(15)24-27-20-10-11-31-14-19(20)23(28-24)26-13-16-6-3-2-4-7-16/h2-9,12H,10-11,13-14H2,1H3,(H2,25,30)(H,26,27,28)

O1C([H])([H])C([H])([H])C2=C(C(N([H])C([H])([H])C3C([H])=C([H])C([H])=C([H])C=3[H])=NC(=N2)N2C(C([H])([H])[H])=C([H])C3=C(C(N([H])[H])=O)C([H])=C([H])C([H])=C23)C1([H])[H]